Pro Medicus Ltd
PME
Company Profile
Business description
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.
Contact
450 Swan Street
RichmondVIC3121
AUST: +61 394298800
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
30 June 2025
Employees
75
Stocks News & Analysis
stocks
Should you avoid this highflying ASX share?
A sound business model but the shares are expensive.
personal-finance
Bookworm: A timely reminder of what can drive a market reversal
David Dreman sought to beat the market by going against the crowd. The mechanisms behind that could explain Nvidia's recent fall.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,133.10 | 6.20 | 0.08% |
| CAC 40 | 7,858.83 | 17.53 | -0.22% |
| DAX 40 | 22,390.84 | 149.14 | -0.66% |
| Dow JONES (US) | 42,050.69 | 60.73 | 0.14% |
| FTSE 100 | 8,608.48 | 26.32 | -0.30% |
| HKSE | 23,202.53 | 4.31 | -0.02% |
| NASDAQ | 17,490.78 | 40.89 | 0.23% |
| Nikkei 225 | 35,725.87 | 101.39 | 0.28% |
| NZX 50 Index | 12,320.19 | 7.59 | 0.06% |
| S&P 500 | 5,641.51 | 8.44 | 0.15% |
| S&P/ASX 200 | 7,934.50 | 9.30 | 0.12% |
| SSE Composite Index | 3,350.13 | 1.69 | 0.05% |